Jason B Liu1,2, Julie A Sosa3, Raymon H Grogan2, Yaoming Liu1, Mark E Cohen1, Clifford Y Ko1,4, Bruce L Hall1,5,6,7. 1. American College of Surgeons, Chicago, Illinois. 2. Department of Surgery, University of Chicago Medicine, Chicago, Illinois. 3. Surgical Center for Outcomes Research, Section of Endocrine Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina. 4. Department of Surgery, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California. 5. Center for Health Policy and the Olin Business School, Department of Surgery, Washington University at St Louis, St Louis, Missouri. 6. St Louis Veterans Affairs Medical Center, St Louis, Missouri. 7. BJC Healthcare, St Louis, Missouri.
Abstract
Importance: Current surgical quality metrics might be insufficient to fully judge the quality of certain operations because they are not procedure specific. Hypocalcemia, recurrent laryngeal nerve (RLN) injury, and hematoma are considered to be the most relevant outcomes to measure after thyroidectomy. Whether these outcomes can be used as hospital quality metrics is unknown. Objectives: To evaluate whether thyroidectomy-specific outcomes vary among hospitals, whether the addition of thyroidectomy-specific variables affects risk adjustment, and whether differences in hospital performance are associated with thyroidectomy-specific care processes. Design, Setting, and Participants: In this retrospective cohort study, patients undergoing thyroidectomies from January 1, 2013, through December 31, 2015, at hospitals participating in the American College of Surgeons' National Surgical Quality Improvement Program were studied. Exposure: Thyroidectomy-related care. Main Outcomes and Measures: Clinically severe hypocalcemia, RLN injury, and clinically significant hematoma within 30 days of thyroid surgery and hospital-level performance variation, change in risk adjustment, and association with processes. Results: Overall, 14 540 patients (mean [SD] age, 52.1 [15.0] years; 11 499 [79.1%] female) underwent operations at 98 hospitals. Because operations missing thyroidectomy-specific outcomes were excluded, the numbers of operations and hospitals analyzed differed by outcome. Of 14 540 operations included, clinically severe hypocalcemia occurred in 450 patients (3.3% overall, 0.6% after partial, and 4.7% after subtotal or total thyroidectomy), RLN injury in 755 patients (5.7% overall, 4.2% after partial, and 6.6% after subtotal or total thyroidectomy), and hematoma in 175 patients (1.3%). Hospital performance varied for hypocalcemia and RLN injury but not for hematoma. Hospital performance rankings were largely unaffected by the inclusion of thyroidectomy-specific data in risk adjustment. With regard to processes, patients undergoing thyroidectomies at the best-performing vs worst-performing hospitals less frequently had their postoperative parathyroid hormone level measured (593 [19.9%] vs 457 [31.7%], P < .001) and more often were prescribed oral calcium, vitamin D, or both (2281 [76.6%] vs 962 [66.8%], P < .001). When profiled by RLN injury, use of energy devices (1517 [69.1%] vs 507 [55.2%], P < .001) and intraoperative nerve monitoring (1223 [55.7%] vs 346 [37.7%], P < .001) were more prevalent at the best- compared with the worst-performing hospitals. Conclusions and Relevance: Postoperative hypocalcemia and RLN injury, but not hematoma, potentially could be used as thyroidectomy-specific national hospital quality improvement metrics. Strategies aimed at reducing these complications after thyroidectomy may improve the care of these patients.
Importance: Current surgical quality metrics might be insufficient to fully judge the quality of certain operations because they are not procedure specific. Hypocalcemia, recurrent laryngeal nerve (RLN) injury, and hematoma are considered to be the most relevant outcomes to measure after thyroidectomy. Whether these outcomes can be used as hospital quality metrics is unknown. Objectives: To evaluate whether thyroidectomy-specific outcomes vary among hospitals, whether the addition of thyroidectomy-specific variables affects risk adjustment, and whether differences in hospital performance are associated with thyroidectomy-specific care processes. Design, Setting, and Participants: In this retrospective cohort study, patients undergoing thyroidectomies from January 1, 2013, through December 31, 2015, at hospitals participating in the American College of Surgeons' National Surgical Quality Improvement Program were studied. Exposure: Thyroidectomy-related care. Main Outcomes and Measures: Clinically severe hypocalcemia, RLN injury, and clinically significant hematoma within 30 days of thyroid surgery and hospital-level performance variation, change in risk adjustment, and association with processes. Results: Overall, 14 540 patients (mean [SD] age, 52.1 [15.0] years; 11 499 [79.1%] female) underwent operations at 98 hospitals. Because operations missing thyroidectomy-specific outcomes were excluded, the numbers of operations and hospitals analyzed differed by outcome. Of 14 540 operations included, clinically severe hypocalcemia occurred in 450 patients (3.3% overall, 0.6% after partial, and 4.7% after subtotal or total thyroidectomy), RLN injury in 755 patients (5.7% overall, 4.2% after partial, and 6.6% after subtotal or total thyroidectomy), and hematoma in 175 patients (1.3%). Hospital performance varied for hypocalcemia and RLN injury but not for hematoma. Hospital performance rankings were largely unaffected by the inclusion of thyroidectomy-specific data in risk adjustment. With regard to processes, patients undergoing thyroidectomies at the best-performing vs worst-performing hospitals less frequently had their postoperative parathyroid hormone level measured (593 [19.9%] vs 457 [31.7%], P < .001) and more often were prescribed oral calcium, vitamin D, or both (2281 [76.6%] vs 962 [66.8%], P < .001). When profiled by RLN injury, use of energy devices (1517 [69.1%] vs 507 [55.2%], P < .001) and intraoperative nerve monitoring (1223 [55.7%] vs 346 [37.7%], P < .001) were more prevalent at the best- compared with the worst-performing hospitals. Conclusions and Relevance: Postoperative hypocalcemia and RLN injury, but not hematoma, potentially could be used as thyroidectomy-specific national hospital quality improvement metrics. Strategies aimed at reducing these complications after thyroidectomy may improve the care of these patients.
Authors: Jason B Liu; Sharon M Weber; Julia R Berian; Shenglin Chen; Mark E Cohen; Clifford Y Ko; Karl Y Bilimoria Journal: JAMA Surg Date: 2016-11-01 Impact factor: 14.766
Authors: Michael G White; Benjamin C James; Cheryl Nocon; Sapna Nagar; Edwin L Kaplan; Peter Angelos; Raymon H Grogan Journal: J Surg Res Date: 2015-11-24 Impact factor: 2.192
Authors: Sujana S Chandrasekhar; Gregory W Randolph; Michael D Seidman; Richard M Rosenfeld; Peter Angelos; Julie Barkmeier-Kraemer; Michael S Benninger; Joel H Blumin; Gregory Dennis; John Hanks; Megan R Haymart; Richard T Kloos; Brenda Seals; Jerry M Schreibstein; Mack A Thomas; Carolyn Waddington; Barbara Warren; Peter J Robertson Journal: Otolaryngol Head Neck Surg Date: 2013-06 Impact factor: 3.497
Authors: Maurizio De Palma; Ludovico Rosato; Fabiana Zingone; Giulio Orlando; Antonio Antonino; Mario Vitale; Alessandro Puzziello Journal: Am J Surg Date: 2015-07-31 Impact factor: 2.565
Authors: Jennifer M Siu; Justin C McCarty; Shekhar Gadkaree; Edward J Caterson; Gregory Randolph; Ian J Witterick; Antoine Eskander; Regan W Bergmark Journal: JAMA Surg Date: 2019-11-20 Impact factor: 14.766
Authors: Vivian Hsiao; Dawn M Elfenbein; Susan C Pitt; Kristin L Long; Rebecca S Sippel; David F Schneider Journal: J Surg Res Date: 2021-12-10 Impact factor: 2.192
Authors: Xavier M Keutgen; Hui Li; Kelvin Memeh; Julian Conn Busch; Jelani Williams; Li Lan; David Sarne; Brendan Finnerty; Peter Angelos; Thomas J Fahey; Maryellen L Giger Journal: J Med Imaging (Bellingham) Date: 2022-05-26
Authors: Syed Z Ali; Allan Siperstein; Peter M Sadow; Allan C Golding; Giulia C Kennedy; Richard T Kloos; Paul W Ladenson Journal: Cancer Cytopathol Date: 2019-04-24 Impact factor: 4.264
Authors: Sadaf Mohtashami; Keith Richardson; Veronique-Isabelle Forest; Alex Mlynarek; Richard J Payne; Michael Tamilia; Marc P Pusztaszeri; Michael P Hier; Nader Sadeghi; Marco A Mascarella Journal: Ann Otol Rhinol Laryngol Date: 2021-06-01 Impact factor: 1.547